# Group A Pharyngitis in Children: The GASPARD Study

> **NCT03264911** · PHASE4 · UNKNOWN · sponsor: **Klara Posfay-Barbe** · enrollment: 360 (estimated)

## Conditions studied

- Group A Streptococcal Pharyngitis

## Interventions

- **DRUG:** Amoxicillin or Placebo

## Key facts

- **NCT ID:** NCT03264911
- **Lead sponsor:** Klara Posfay-Barbe
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-27
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2017-08-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03264911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03264911, "Group A Pharyngitis in Children: The GASPARD Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03264911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*